| Market cap | Sales (TTM) | Net profit (TTM) | P/E | EPS (TTM) | P/B | ROE | Beta |
|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | 1.40 |
| Method | Checks | Score | Verdict |
|---|---|---|---|
| Minervini | ✗ Close above the 150- and 200-day averages ✗ 150-day above 200-day ✗ 200-day rising for a month ✗ 50-day above the 150- and 200-day ✓ Close above the 50-day ✗ At least 25% above the 52-week low · low 27.09 ✗ Within 25% of the 52-week high · high 64.25 ✗ RS percentile 70 or more · RS 7 Minervini's trend template - the gate the scanner applies. | 1/8 | 1 of 8 |
| Weinstein | Stan Weinstein's stage analysis on the 30-week moving average. | Stage 4 - declining | |
| CAN SLIM | — C latest quarter EPS up 25%+, with sales up 25%+ or accelerating — A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✗ N (proxy) near the 52-week high - within 15% · high 64.25 ✗ S (proxy) more volume on up days than down days (50 sessions) · 0.83x ✗ L RS percentile 80 or more · RS 7 — I (proxy) FII + DII holding trend · not yet collected for this stock ✗ M (proxy) market in an uptrend, 40%+ of stocks above their 200-day - shared, not counted · breadth 40% William O'Neil's growth-leader checklist, as a checklist score: the six stock letters counted equally, though O'Neil read them together. M is the market condition, shown but not counted. N, S, I and M are proxies. | 0/3 | Weak |
| Darvas | ✗ New 52-week high in the last 120 sessions Darvas needs a new 52-week high to start a box. | 10/100 | No box |
| Turtle | ✗ Close above the prior 55-session high · 33.00 ✓ Close above the prior 20-session high · 30.65 ✗ Close below the prior 20-session low (also a Turtle exit level) · 26.31 Turtle-inspired long breakout: the Turtle traders' entry channels only - no exits, stops or position sizing. | Breakout (20-day) | |
| Graham | Needs positive earnings and book value. | Not assessable |
| Stock | 1M % | 3M % | 6M % | 1Y % | 3Y % | 5Y % | P/E | P/B | ROE % | ROCE % | ROA % | D/E | EV/EBITDA | ₹ Cr | Sales TTM ₹ Cr | Profit TTM ₹ Cr | EPS | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BYKE this stock | +7.6 | -10.0 | -15.5 | -49.5 | -28.6 | -16.8 | — | — | — | — | — | — | — | — | — | — | — | 1.40 |
| SAKAR | -12.1 | +2.4 | +50.4 | +153.8 | +172.7 | +515.1 | 49.1 | 6.07 | 10.0 | 12.9 | 6.80 | 0.13 | 22.9 | 2,102 | 302 | 43 | 19.2 | 0.67 |
| AHCL | -22.7 | +72.7 | +91.0 | +88.2 | — | — | 10.5 | 5.25 | 47.4 | — | — | 0.28 | 20.1 | 1,350 | — | — | 2.4 | 0.43 |
| ENTERO | -5.9 | +28.2 | +30.0 | +43.2 | — | — | 54.9 | 4.08 | 6.7 | 10.7 | 4.63 | 0.34 | 26.2 | 6,883 | 7,128 | 168 | 28.8 | 0.34 |
| AMANTA | -9.4 | +0.2 | +31.5 | +42.8 | — | — | 41.5 | 2.69 | — | — | — | 1.06 | — | — | 291 | 15 | 4.2 | 0.78 |
| VIJAYA | +1.3 | +6.9 | +28.1 | +41.9 | +149.6 | +156.2 | 79.4 | 15.56 | 19.7 | 30.3 | 12.44 | 0.00 | 41.8 | 14,890 | 857 | 188 | 18.2 | 0.50 |
| YATHARTH | -5.0 | +17.7 | +19.7 | +20.6 | +171.4 | — | 52.2 | 5.24 | 10.0 | 12.4 | 8.49 | 0.14 | 28.5 | 9,461 | 1,334 | 174 | 18.8 | 0.90 |
| LALPATHLAB | -4.0 | +1.3 | +40.9 | +18.3 | +48.4 | +6.5 | 59.3 | 12.87 | 21.6 | 29.1 | 17.39 | 0.00 | 36.8 | 32,275 | 2,891 | 546 | 32.5 | 0.39 |
| METROPOLIS | +5.7 | -4.7 | +19.4 | +13.5 | +54.5 | -25.6 | 58.4 | 7.79 | 13.4 | 19.6 | 9.55 | 0.01 | 27.7 | 11,791 | 1,710 | 203 | 9.7 | 0.45 |
| APOLLOHOSP | +3.8 | -4.3 | +10.5 | +7.9 | +63.8 | +90.2 | 58.1 | 12.80 | 21.9 | 20.7 | 9.35 | 0.60 | 32.1 | 1.21L | 26,430 | 2,172 | 145.3 | 0.56 |
| STARHEALTH | -2.8 | -11.8 | -0.6 | +7.3 | -4.3 | — | 27.6 | 3.03 | 11.0 | — | — | — | — | 30,698 | — | — | 18.9 | 0.39 |
← All NSE stocks · More Hospitals & Diagnostics stocks